Ito Taisei, Ohuchi Kazuki, Kurita Hisaka, Murakami Takanori, Takizawa Shinnosuke, Fujimaki Ayaka, Murata Junya, Oida Yasuhisa, Hozumi Isao, Kitaichi Kiyoyuki, Inden Masatoshi
Laboratory of Medical Therapeutics and Molecular Therapeutics, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan.
Laboratory of Pharmaceutics, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan.
Biol Pharm Bull. 2025;48(2):93-100. doi: 10.1248/bpb.b24-00794.
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by selective motor neuron cell death. A GGGGCC hexanucleotide repeat expansion (HRE) within the chromosome 9 open reading frame 72 (C9orf72) gene is a major causative factor in ALS. This abnormal HRE triggers five types of dipeptide repeat protein (DPR), each composed of two alternating amino acid expressions. Among the DPRs, arginine-rich Poly-PR localizes predominantly to the nucleus, exerting particularly strong toxicity on motor and cortical neurons. Several mechanisms have been proposed for poly-PR-induced neurotoxicity. In this study, poly-PR-expressing NSC34 motor neuron-like cells showed an increase in oxidative stress. Fibroblast growth factor receptor 1 (FGFR1) is known to promote neurogenesis and inhibit apoptosis in neurons. However, its neuroprotective effects against DPR-induced toxicity have not been previously reported. Here, we demonstrated that FGFR1 activation reduced oxidative stress by upregulating nuclear factor erythroid 2-related factor 2 (NRF2) expression. Furthermore, we propose that the increase in NRF2 through FGFR1 activation may result from the alleviation of protein translation impairment. Overall, these findings suggest that FGFR1 activation provides neuroprotection against poly-PR toxicity and may represent a potential therapeutic strategy for ALS.
肌萎缩侧索硬化症(ALS)是一种神经退行性疾病,其特征为选择性运动神经元细胞死亡。9号染色体开放阅读框72(C9orf72)基因内的一个GGGGCC六核苷酸重复扩增(HRE)是ALS的主要致病因素。这种异常的HRE会触发五种类型的二肽重复蛋白(DPR),每种由两个交替的氨基酸表达组成。在这些DPR中,富含精氨酸的聚PR主要定位于细胞核,对运动神经元和皮质神经元具有特别强的毒性。关于聚PR诱导神经毒性的机制,已经提出了几种。在本研究中,表达聚PR的NSC34运动神经元样细胞显示氧化应激增加。成纤维细胞生长因子受体1(FGFR1)已知可促进神经发生并抑制神经元凋亡。然而,其对DPR诱导毒性的神经保护作用此前尚未见报道。在此,我们证明FGFR1激活通过上调核因子红细胞2相关因子2(NRF2)的表达来降低氧化应激。此外,我们提出通过FGFR1激活使NRF2增加可能是由于蛋白质翻译损伤的减轻。总体而言,这些发现表明FGFR1激活可提供针对聚PR毒性的神经保护作用,可能代表一种针对ALS的潜在治疗策略。